B H Wolffenbuttel

Summary

Affiliation: University Hospital Maastricht
Country: The Netherlands

Publications

  1. ncbi request reprint Comparison of different insulin regimens in elderly patients with NIDDM
    B H Wolffenbuttel
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Diabetes Care 19:1326-32. 1996
  2. ncbi request reprint [Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control]
    B H R Wolffenbuttel
    Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastricht
    Ned Tijdschr Geneeskd 146:654-8. 2002
  3. ncbi request reprint [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]
    B H Wolffenbuttel
    Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastrict
    Ned Tijdschr Geneeskd 145:761-5. 2001
  4. ncbi request reprint Rosiglitazone
    B H Wolffenbuttel
    Dept of Endocrinology and Metabolism, University Hospital Maastricht, P O Box 5800, NL 6202 AZ Maastricht, The Netherlands
    Expert Opin Pharmacother 2:467-78. 2001
  5. ncbi request reprint Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients
    B H Wolffenbuttel
    University Hospital Maastricht, The Netherlands
    Diabet Med 17:40-7. 2000
  6. ncbi request reprint Repaglinide--a new compound for the treatment of patients with type 2 diabetes
    B H Wolffenbuttel
    Dept of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Neth J Med 55:229-34. 1999
  7. ncbi request reprint [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications]
    B H Wolffenbuttel
    Afd Endocrinologie, Academisch Ziekenhuis Maastricht
    Ned Tijdschr Geneeskd 143:1197-201. 1999
  8. ncbi request reprint A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group
    B H Wolffenbuttel
    Department of Endocrinology, University Hospital Maastricht, The Netherlands
    Diabetes Care 22:463-7. 1999
  9. ncbi request reprint Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome
    B H Wolffenbuttel
    Department of Endocrinology, University Hospital Maastricht, The Netherlands
    Clin Neurol Neurosurg 100:60-3. 1998
  10. ncbi request reprint Prognostic factors for successful insulin therapy in subjects with type 2 diabetes
    B H Wolffenbuttel
    Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Neth J Med 54:63-9. 1999

Collaborators

Detail Information

Publications30

  1. ncbi request reprint Comparison of different insulin regimens in elderly patients with NIDDM
    B H Wolffenbuttel
    Department of Internal Medicine, University Hospital Maastricht, The Netherlands
    Diabetes Care 19:1326-32. 1996
    ....
  2. ncbi request reprint [Postprandial glucose peaks in the pathogenesis of cardiovascular disease in diabetes mellitus; implications for metabolic control]
    B H R Wolffenbuttel
    Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastricht
    Ned Tijdschr Geneeskd 146:654-8. 2002
    ..People suffering from diabetes are best advised to direct their self control also at the bloodglucose level 1.5-2 h after a meal...
  3. ncbi request reprint [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2]
    B H Wolffenbuttel
    Academisch Ziekenhuis, Afd Endocrinologie, Postbus 5800, 6202 AZ Maastrict
    Ned Tijdschr Geneeskd 145:761-5. 2001
    ....
  4. ncbi request reprint Rosiglitazone
    B H Wolffenbuttel
    Dept of Endocrinology and Metabolism, University Hospital Maastricht, P O Box 5800, NL 6202 AZ Maastricht, The Netherlands
    Expert Opin Pharmacother 2:467-78. 2001
    ..Additional studies will also explore its long-term effects in sparing beta-cell function and reducing diabetes-related complications and atherosclerosis...
  5. ncbi request reprint Addition of low-dose rosiglitazone to sulphonylurea therapy improves glycaemic control in Type 2 diabetic patients
    B H Wolffenbuttel
    University Hospital Maastricht, The Netherlands
    Diabet Med 17:40-7. 2000
    ..This study was designed to test the efficacy and safety of low-dose rosiglitazone, a potent, insulin-sensitizing thiazolidinedione, in combination with sulphonylurea in Type 2 diabetic patients...
  6. ncbi request reprint Repaglinide--a new compound for the treatment of patients with type 2 diabetes
    B H Wolffenbuttel
    Dept of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Neth J Med 55:229-34. 1999
    ..Although the overall incidence of hypoglycaemia was similar during use of repaglinide and of sulphonylurea, fewer serious hypoglycaemic episodes were observed in repaglinide-treated patients...
  7. ncbi request reprint [Glycemic regulation and management of essential hypertension in diabetics with type 2 diabetes mellitus; the 'United Kingdom prospective diabetes study' of diabetic complications]
    B H Wolffenbuttel
    Afd Endocrinologie, Academisch Ziekenhuis Maastricht
    Ned Tijdschr Geneeskd 143:1197-201. 1999
    ..Non of the antihypertensive drugs used (an ACE inhibitor and a beta-blocking agent) offered any advantages over the other...
  8. ncbi request reprint A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Dutch and German Repaglinide Study Group
    B H Wolffenbuttel
    Department of Endocrinology, University Hospital Maastricht, The Netherlands
    Diabetes Care 22:463-7. 1999
    ..This multicenter study was designed to compare the efficacy and safety of this drug with glyburide in a 1-year randomized double-blind study of outpatients with type 2 diabetes...
  9. ncbi request reprint Beneficial gamma-knife radiosurgery in a patient with Nelson's syndrome
    B H Wolffenbuttel
    Department of Endocrinology, University Hospital Maastricht, The Netherlands
    Clin Neurol Neurosurg 100:60-3. 1998
    ..It is concluded that gamma-knife radiosurgery may be a good alternative for patients with Nelson's syndrome who have rapidly recurring disease...
  10. ncbi request reprint Prognostic factors for successful insulin therapy in subjects with type 2 diabetes
    B H Wolffenbuttel
    Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Neth J Med 54:63-9. 1999
    ..To assess which factors influence or predict the efficacy of insulin therapy in subjects with type 2 diabetes, who were poorly controlled despite maximal doses of oral glucose lowering agents...
  11. ncbi request reprint Efficacy and safety of a new cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin and pravastatin, in subjects with hypercholesterolemia
    B H Wolffenbuttel
    Department of Endocrinology and Metabolism, University Hospital Maastricht, Netherlands
    Neth J Med 52:131-7. 1998
    ..In a 16-week, multicenter, randomized, open-label cross-over study we compared the efficacy and safety of the new compound atorvastatin for reducing LDL-cholesterol with simvastatin or pravastatin...
  12. ncbi request reprint Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients
    W A Oranje
    Department of Endocrinology and Metabolism, University Hospital Maastricht, Maastricht, The Netherlands
    Clin Chim Acta 311:91-4. 2001
    ..Oxidative stress in diabetes increases lipid peroxidation, which stimulates the development of atherosclerosis...
  13. ncbi request reprint Arteriolar reactivity in conscious diabetic rats: influence of aminoguanidine treatment
    F R Crijns
    Department of Endocrinology and Metabolism, Cardiovascular Research Institute, University Hospital Maastricht, The Netherlands
    Diabetes 47:918-23. 1998
    ..05 vs. untreated control rats). These data indicate that 6 weeks of experimental diabetes is associated with a decreased endothelium-dependent and -independent vasodilatation. AG treatment had no beneficial effect on this disturbance...
  14. ncbi request reprint Lipid peroxidation in type 2 diabetes: relationship with macrovascular disease?
    W A Oranje
    Dept of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Neth J Med 53:61-8. 1998
    ..Macrovascular disease is the leading cause of death in diabetes. The increased risk of atherosclerosis in diabetes may be partly explained by increased lipid peroxidation...
  15. ncbi request reprint Mechanical properties of mesenteric arteries in diabetic rats: consequences of outward remodeling
    F R Crijns
    Department of Endocrinology and Metabolism, Cardiovascular Research Institute Maastricht, University Hospital Maastricht, 6202 AZ Maastricht, The Netherlands
    Am J Physiol 276:H1672-7. 1999
    ..These results indicate that mesenteric small arteries of diabetic rats display eutrophic outward remodeling associated with increased wall tension and circumferential wall stress...
  16. ncbi request reprint Effects of acarbose (Glucobay) in persons with type 1 diabetes: a multicentre study
    J P Sels
    Department of Endocrinology and Metabolism, University Hospital Maastricht, The Netherlands
    Diabetes Res Clin Pract 41:139-45. 1998
    ..We conclude that acarbose up to 3 x 100 mg/day can be a valuable adjunct to insulin in improving metabolic control in persons with type 1 diabetes...
  17. ncbi request reprint Miglitol, a new alpha-glucosidase inhibitor
    J P Sels
    Department of Endocrinology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, The Netherlands
    Expert Opin Pharmacother 1:149-56. 1999
    ..More long-term data are needed to fully assess to the clinical use of miglitol in these patients...
  18. ncbi request reprint Pitfall of the accessory spleen
    J P Sels
    Department of Endocrinology, University Hospital Maastricht, P O Box 5800, 6202 AZ, Maastricht, The Netherlands
    Neth J Med 56:153-8. 2000
    ..The insulinoma was identified as such during laparotomy, whereas additional jodo-cholesterol scintigraphy revealed the real nature of the lesion in the patient with Cushing's syndrome. Both patients were operated successfully...
  19. ncbi request reprint Clinical experience with Sandostatin LAR in patients with acromegaly
    C A Heijckmann
    Department of Endocrinology, University Hospital Maastricht, P.O. Box 5800, NL-6202 AZ Maastricht, The Netherlands
    Neth J Med 59:286-91. 2001
    ..In six patients, the dose had to be increased to 30-40 mg monthly because the IGF-1 levels still remained elevated. Sandostatin LAR may be considered a great improvement for the treatment of patients with (symptomatic) acromegaly...
  20. ncbi request reprint Cytochrome P450, peroxisome proliferation, and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat
    W Engels
    Department of Internal Medicine, Maastricht University, The Netherlands
    Mol Cell Biochem 192:53-61. 1999
    ..Consequently, it is not likely that dicarboxylic acids are involved in the induction of peroxisome proliferation in the heart...
  21. ncbi request reprint CETP inhibition in cardiovascular risk management: a critical appraisal
    R P F Dullaart
    University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Eur J Clin Invest 37:90-8. 2007
    ..We propose that low HDL cholesterol in the context of high triglycerides, such as found in type 2 diabetes mellitus, could become an important indication area for this new class of drugs...
  22. ncbi request reprint Preoperative pharmacological management of phaeochromocytoma
    A N A van der Horst-Schrivers
    Department of Endocrinology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands
    Neth J Med 64:290-5. 2006
    ..We reviewed the relevant literature on this subject. In addition, we compared the several preoperative treatment protocols of the eight university medical centres in the Netherlands...
  23. ncbi request reprint Time course of specific AGEs during optimised glycaemic control in type 2 diabetes
    C J A L Mentink
    Department of Human Biology, Faculty of Health Sciences, Maastricht University, Maastricht, The Netherlands
    Neth J Med 64:10-6. 2006
    ..Although serum AGEs correlate with average glycaemic control in patients with type 2 diabetes and predict the development of complications, it is not known how serum AGEs change during optimisation of diabetes therapy...
  24. ncbi request reprint Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus
    R De Vries
    Department of Endocrinology, University Medical Center Groningen, University of Groningen, P O Box 30 001, RB 9700 Groningen, The Netherlands
    Diabetologia 49:398-404. 2006
    ..We analysed the relationship between carotid artery intima-media thickness (IMT), an established marker of atherosclerosis, and PLTP activity in diabetic patients and control subjects...
  25. ncbi request reprint [Missed hyperinsulinaemia in a patient with an insulinoma]
    R S M E Wouters
    afd Interne Geneeskunde, Scheper Ziekenhuis, Boermarkeweg 60, 7824 AA Emmen
    Ned Tijdschr Geneeskd 149:944-6. 2005
    ..Therefore new normative values are needed for the newer insulin assays when diagnosing an insulin-producing islet cell tumour. Pro-insulin and C-peptide assays may play a useful role in this...
  26. ncbi request reprint Do diabetologists recognise self-management problems in their patients?
    J C Keers
    Northern Centre for Healthcare Research, P O Box 196, Groningen 9700 AD, The Netherlands
    Diabetes Res Clin Pract 66:157-61. 2004
    ..The aim of this study was to determine whether diabetologists recognise patients' needs for additional intensive multidisciplinary care due to glycaemic and diabetes-related psychosocial difficulties...
  27. ncbi request reprint Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes
    S R Heller
    Northern General Hospital, Sheffield S5 7AU, UK
    Diabet Med 21:769-75. 2004
    ....
  28. pmc Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a)
    F Hartgens
    Netherlands Centre for Doping Affairs, Capelle aan den IJssel, The Netherlands
    Br J Sports Med 38:253-9. 2004
    ....
  29. ncbi request reprint Resource consumption and costs in Dutch patients with type 2 diabetes mellitus. Results from 29 general practices
    W K Redekop
    Institute for Medical Technology Assessment iMTA, Erasmus University Rotterdam, Rotterdam, The Netherlands
    Diabet Med 19:246-53. 2002
    ....
  30. ncbi request reprint [The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60]
    M B Bos
    Rijksinstituut voor Volksgezondheid en Milieu, Centrum voor Voeding en Gezondheid, Bilthoven
    Ned Tijdschr Geneeskd 151:2382-8. 2007
    ..To estimate the prevalence of the metabolic syndrome in the Netherlands in two populations in the age category 28-59 years and to compare this with the prevalence of hypercholesterolaemia in these populations...